State of play in advanced prostate cancer: a multi-disciplinary expert discussion

Janssen sponsored industry session at EMUC 2021

Learning objective:         

After attending this symposium, participants should be able to:

  • Analyse and apply the most recent advances in mHSPC to daily practical management
  • Discuss the consequences of treatment choices in mHSPC on sequencing in mCRPC


Scientific committee:

  • Elena Castro (Spain)
  • Axel Merseburger (Germany)



  • Stefano Fanti (Italy)
  • Thomas Zilli (Switzerland)

More Info
56 Minutes
EM-78855 - Date of preparation: November 2021